Ozempic - what’s the deal?! Ozempic is a glucagon-like peptide 1 (GLP 1) agonist, which is a medication that is used to help control the body’s average blood sugar level. It is used for patients with diabetes to reduce insulin resistance and improve hemoglobin A1c. The medication, whose chemical name is Semaglutide, was approved by the FDA for use in diabetic patients in late 2017. It was been an excellent addition to management of diabetes. So why do we hear about this in the media? Semaglutide is also highly effective as an adjunct to diet and exercise, for weight loss. In June 2021, Semaglutide under a different trade name - Wegovy - was appropriated to help with weight loss. This medication as well as other anti-obesity medications- are indicated for patients with BMI >30 or BMI >27 with weight related conditions. The medication is very effective with nearly half of study participants seeing a 15% weight loss. All this has been very excited for those of us who treat overweight and obesity. The problem is that this life changing the medication is only available in brand name which makes it very expensive, and it is also in limited supply. With ~40% or the US population having obesity and ~70% having overweight, the issue of who should get this medication is an important public health dialogue. Also, with health care mostly dictated by a combination of proprietary insurance companies and personal wealth - this Life